Tnf Pharmaceuticals, Stock Cash And Equivalents
| TNFA Stock | 1.29 0.07 5.15% |
TNF Pharmaceuticals, fundamentals help investors to digest information that contributes to TNF Pharmaceuticals,'s financial success or failures. It also enables traders to predict the movement of TNF Stock. The fundamental analysis module provides a way to measure TNF Pharmaceuticals,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TNF Pharmaceuticals, stock.
TNF | Cash And Equivalents |
TNF Pharmaceuticals, Company Cash And Equivalents Analysis
TNF Pharmaceuticals,'s Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
TNF Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for TNF Pharmaceuticals, is extremely important. It helps to project a fair market value of TNF Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since TNF Pharmaceuticals,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TNF Pharmaceuticals,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TNF Pharmaceuticals,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, TNF Pharmaceuticals, has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
TNF Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TNF Pharmaceuticals,'s direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics of similar companies.TNF Pharmaceuticals, is currently under evaluation in cash and equivalents category among its peers.
TNF Pharmaceuticals, Current Valuation Drivers
We derive many important indicators used in calculating different scores of TNF Pharmaceuticals, from analyzing TNF Pharmaceuticals,'s financial statements. These drivers represent accounts that assess TNF Pharmaceuticals,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of TNF Pharmaceuticals,'s important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 19.5K | 224.5K | 2.2M | 2.5M | 2.9M | 3.1M | |
| Enterprise Value | 507.0K | (14.3M) | 1.8M | 1.9M | 313.9K | 329.6K |
TNF Fundamentals
| Return On Equity | -2.98 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | (9.48 M) | ||||
| Shares Outstanding | 2.37 M | ||||
| Shares Owned By Insiders | 6.44 % | ||||
| Shares Owned By Institutions | 39.87 % | ||||
| Number Of Shares Shorted | 279.28 K | ||||
| Price To Book | 0.44 X | ||||
| EBITDA | (4 M) | ||||
| Net Income | (4 M) | ||||
| Total Debt | 48.87 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (12.98 M) | ||||
| Short Ratio | 4.97 X | ||||
| Earnings Per Share | (10.48) X | ||||
| Beta | 2.67 | ||||
| Market Capitalization | 3.13 M | ||||
| Total Asset | 17.86 M | ||||
| Retained Earnings | (101.98 M) | ||||
| Working Capital | 828.25 K | ||||
| Net Asset | 17.86 M |
About TNF Pharmaceuticals, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:Check out TNF Pharmaceuticals, Piotroski F Score and TNF Pharmaceuticals, Altman Z Score analysis. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.48) | Return On Assets (0.32) | Return On Equity (2.98) |
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.